Phosphodiesterase type 5 inhibitors improve male lower urinary tract symptoms.
Giuliano
François
F
D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D053448:Prostatism / Q000188:drug therapy*
D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors